NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus

Author's Avatar
Nov 28, 2022

NanoVibronix%2C+Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its PainShield® MD PLUS, its dual-actuator ultrasound pain therapy device.